MRI detection of myocardial perfusion defects due to coronary artery stenosis with MS-325

Dara L Kraitchman1, Bennett B Chin, Alan W Heldman

  • 1Departments of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-0845, USA. dara@mri.jhu.edu

Abstract

Insights

MS-325, an albumin-targeted contrast agent, effectively visualizes myocardial ischemia using magnetic resonance imaging (MRI). This agent aids in detecting perfusion defects by showing prolonged hypoenhancement in ischemic areas.

Area of Science:

  • Cardiovascular Imaging
  • Magnetic Resonance Imaging
  • Myocardial Perfusion Assessment

Background:

  • Myocardial ischemia detection is crucial for diagnosing and managing coronary artery disease.
  • Traditional imaging techniques have limitations in sensitivity and specificity.
  • Novel contrast agents are needed to improve diagnostic accuracy.

Purpose of the Study:

  • To evaluate the diagnostic performance of MS-325, an intravascular, albumin-targeted contrast agent, for visualizing myocardial ischemia using MRI.
  • To compare the efficacy of MS-325 enhanced MRI with established methods like SPECT for myocardial perfusion assessment.

Main Methods:

  • Created left anterior descending coronary artery (LAD) stenosis in pigs to induce myocardial ischemia.
  • Utilized first-pass, contrast-enhanced MRI during dipyridamole stress to detect ischemia.
  • Compared MRI findings with Technetium-99m (Tc-99m) sestamibi single-photon emission computed tomography (SPECT) and measured regional coronary blood flow using microspheres.

Main Results:

  • Successfully induced myocardial ischemia in 8 out of 19 animals, characterized by >40% reduction in stress myocardial blood flow.
  • MRI detected perfusion defects with 92.3% sensitivity (defined as > or =75% reduction in peak myocardial signal intensity).
  • Achieved 85% concordance between MRI and SPECT in identifying perfusion defects, with uniform enhancement observed in mild stenosis cases.

Conclusions:

  • MS-325 demonstrates significant value in visualizing myocardial ischemia via MRI.
  • The agent's albumin-binding property leads to prolonged, persistent hypoenhancement in ischemic myocardial beds, facilitating defect detection.
  • MS-325 enhanced MRI shows promise as a reliable tool for assessing myocardial perfusion defects.

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...